Alberto M Borobia - JoVE Visualize

Showing results (71-80 of 105) with videos related to

Pageof 11

Sort By:

Human Vaccines & Immunotherapeutics|February 17, 2026

Safety and immunogenicity of an investigational mRNA-lipid nanoparticle-based monovalent influenza vaccine: Results from a phase 1, randomized, dose-escalation studyIsabel Leroux-Roels, Ilse De Coster, Alberto M Borobia, et al.

Journal of Clinical Medicine|October 14, 2023

Krebs von den Lungen-6 (KL-6) Levels in Post-COVID Follow-Up: Differences According to the Severity of COVID-19Carlos Carpio, Ana Qasem, Antonio Buño, et al.

Advances in Laboratory Medicine|May 15, 2026

Pharmacogenetic biomarkers for predicting therapeutic response to JAK inhibitors in rheumatoid arthritisChamaida Plasencia-Rodríguez, Marta Novella-Navarro, Juan Luis Valdivieso Shephard, et al.

International Journal of Molecular Sciences|June 28, 2023

Prognostic Impact of Dihydropyrimidine Dehydrogenase Germline Variants in Unresectable Non-Small Cell Lung Cancer Patients Treated with Platin-Based ChemotherapyJavier Guijarro-Eguinoa, Sara Arjona-Hernandez, Stefan Stewart, et al.

BMJ Open|July 10, 2023

Identifying biomarkers of treatment response to ciclosporin in atopic dermatitis through multiomic predictive modelling: DERMATOMICS study protocolAlicia Marín-Candón, Irene García-García, Pedro Arias, et al.

BMJ Open|January 11, 2020

Study protocol for a phase II, multicentre, prospective, non-randomised clinical trial to assess the safety and efficacy of infusing allogeneic activated and expanded natural killer cells as consolidation therapy for paediatric acute myeloblastic leukaemiaMario Muñoz Builes, María Vela Cuenca, Jose L Fuster Soler, et al.

Frontiers in Medicine|December 16, 2020

Beneficial Effect of Systemic Allogeneic Adipose Derived Mesenchymal Cells on the Clinical, Inflammatory and Immunologic Status of a Patient With Recessive Dystrophic Epidermolysis Bullosa: A Case ReportRocío Maseda, Lucía Martínez-Santamaría, Rosa Sacedón, et al.

Oncotarget|March 9, 2018

Molecular characterization of breast cancer cell response to metabolic drugsLucía Trilla-Fuertes, Angelo Gámez-Pozo, Jorge M Arevalillo, et al.

Digital Health|October 18, 2024

Dubbing language-therapy CINEma-based in aphasia post-stroke (DULCINEA): A feasibility randomized crossover controlled trialBlanca Fuentes, Pablo Jordi-Perea, Cristian Sempere-Iborra, et al.

The Lancet. Respiratory Medicine|June 5, 2015

Acute respiratory distress syndrome after convalescent plasma use: treatment of a patient with Ebola virus disease contracted in Madrid, SpainMarta Mora-Rillo, Marta Arsuaga, Germán Ramírez-Olivencia, et al.

Pageof 11

Showing results (71-80 of 105) with videos related to

Sort By:

Pageof 11

Human Vaccines & Immunotherapeutics|February 17, 2026

Safety and immunogenicity of an investigational mRNA-lipid nanoparticle-based monovalent influenza vaccine: Results from a phase 1, randomized, dose-escalation studyIsabel Leroux-Roels, Ilse De Coster, Alberto M Borobia, et al.

Journal of Clinical Medicine|October 14, 2023

Krebs von den Lungen-6 (KL-6) Levels in Post-COVID Follow-Up: Differences According to the Severity of COVID-19Carlos Carpio, Ana Qasem, Antonio Buño, et al.

Advances in Laboratory Medicine|May 15, 2026

Pharmacogenetic biomarkers for predicting therapeutic response to JAK inhibitors in rheumatoid arthritisChamaida Plasencia-Rodríguez, Marta Novella-Navarro, Juan Luis Valdivieso Shephard, et al.

International Journal of Molecular Sciences|June 28, 2023

Prognostic Impact of Dihydropyrimidine Dehydrogenase Germline Variants in Unresectable Non-Small Cell Lung Cancer Patients Treated with Platin-Based ChemotherapyJavier Guijarro-Eguinoa, Sara Arjona-Hernandez, Stefan Stewart, et al.

BMJ Open|July 10, 2023

Identifying biomarkers of treatment response to ciclosporin in atopic dermatitis through multiomic predictive modelling: DERMATOMICS study protocolAlicia Marín-Candón, Irene García-García, Pedro Arias, et al.

BMJ Open|January 11, 2020

Study protocol for a phase II, multicentre, prospective, non-randomised clinical trial to assess the safety and efficacy of infusing allogeneic activated and expanded natural killer cells as consolidation therapy for paediatric acute myeloblastic leukaemiaMario Muñoz Builes, María Vela Cuenca, Jose L Fuster Soler, et al.

Frontiers in Medicine|December 16, 2020

Beneficial Effect of Systemic Allogeneic Adipose Derived Mesenchymal Cells on the Clinical, Inflammatory and Immunologic Status of a Patient With Recessive Dystrophic Epidermolysis Bullosa: A Case ReportRocío Maseda, Lucía Martínez-Santamaría, Rosa Sacedón, et al.

Oncotarget|March 9, 2018

Molecular characterization of breast cancer cell response to metabolic drugsLucía Trilla-Fuertes, Angelo Gámez-Pozo, Jorge M Arevalillo, et al.

Digital Health|October 18, 2024

Dubbing language-therapy CINEma-based in aphasia post-stroke (DULCINEA): A feasibility randomized crossover controlled trialBlanca Fuentes, Pablo Jordi-Perea, Cristian Sempere-Iborra, et al.

The Lancet. Respiratory Medicine|June 5, 2015

Acute respiratory distress syndrome after convalescent plasma use: treatment of a patient with Ebola virus disease contracted in Madrid, SpainMarta Mora-Rillo, Marta Arsuaga, Germán Ramírez-Olivencia, et al.

Pageof 11